Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-26

Clinical Trial Update: Long-term Study With Clevudine [Phase 4]

View source ↗

Summary

This update reports the completion of a long-term Phase 4 study evaluating clevudine in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevudine (clevudine)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED